IL326346A - Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl - Google Patents

Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl

Info

Publication number
IL326346A
IL326346A IL326346A IL32634626A IL326346A IL 326346 A IL326346 A IL 326346A IL 326346 A IL326346 A IL 326346A IL 32634626 A IL32634626 A IL 32634626A IL 326346 A IL326346 A IL 326346A
Authority
IL
Israel
Prior art keywords
piperidin
quinoline
trifluoromethyl
amino
crystalline form
Prior art date
Application number
IL326346A
Other languages
Hebrew (he)
Inventor
Sylvia Schmidt
Harald Untenecker
Original Assignee
Merck Patent Gmbh
Sylvia Schmidt
Harald Untenecker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh, Sylvia Schmidt, Harald Untenecker filed Critical Merck Patent Gmbh
Publication of IL326346A publication Critical patent/IL326346A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
IL326346A 2023-08-09 2024-08-08 Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl IL326346A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23190662 2023-08-09
PCT/EP2024/072504 WO2025032190A1 (en) 2023-08-09 2024-08-08 Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl

Publications (1)

Publication Number Publication Date
IL326346A true IL326346A (en) 2026-04-01

Family

ID=87567256

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326346A IL326346A (en) 2023-08-09 2024-08-08 Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl

Country Status (5)

Country Link
KR (1) KR20260049277A (en)
CN (1) CN121843928A (en)
AU (1) AU2024321551A1 (en)
IL (1) IL326346A (en)
WO (1) WO2025032190A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3005766A1 (en) 2015-12-17 2017-06-22 Merck Patent Gmbh Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders

Also Published As

Publication number Publication date
AU2024321551A1 (en) 2026-03-26
KR20260049277A (en) 2026-04-13
CN121843928A (en) 2026-04-10
WO2025032190A1 (en) 2025-02-13

Similar Documents

Publication Publication Date Title
IL316075A (en) Crystalline form of lanifibranor
ZA200809820B (en) A novel crystalline form of lamivudine
SI3908584T1 (en) Crystalline forms of 1-(1,2-dimethylpropyl)-n-ethyl-5-methyl-n-pyridazin-4-yl-pyrazole-4-carboxamide
MX2025003559A (en) Novel crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-4-fluoro-piperidin-1-yl)-propenone, salt forms thereof, and processes to obtain
MX2020010866A (en) Novel compounds useful as potassium channel openers.
MY151229A (en) Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
IL318054A (en) Crystalline forms of 1,2,4-oxadiazole fungicides
GB202102360D0 (en) Crystalline compound
IL326346A (en) Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl
MX2011005611A (en) Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvi nyl)pyrimidine.
MX2020004974A (en) Use of carbamate compound for reducing or treating developmental disorders including fragile x syndrome, angelman syndrome or rett syndrome.
CA3300925A1 (en) Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl
WO2008081476A3 (en) Process for preparing duloxetine hydrochloride
IL325727A (en) Crystalline form
IL326278A (en) Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate
IL326355A (en) Crystalline form of 5-((3r,5s)-3-amino-5-trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile
CA3300783A1 (en) Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate
IL308946A (en) Crystalline forms of (s, e)-4-(dimethylamino)-n-(3-(4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl)but-2-enamide free base
WO2013002660A3 (en) Process
CA3300929A1 (en) Crystalline form of 5-((3r,5s)-3-amino-5-trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile
EP4114823A4 (en) Processes for producing amide compounds, and their crystalline and salt form
MX2007000906A (en) Method for producing 3-(4-piperidinyl)-2, 3, 4, 5-tetrahydro-1, 3-benzodiazepin -2(1h)-on.
IL320718A (en) Crystalline forms of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1h-imidazole
MX2010002300A (en) Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl ) -amino) -methyl) -phenoxy) -acetic acid sodium salt or a hydrate thereof and methods for making the same.
GB202217726D0 (en) Crystalline compound